Antigen glycosylation regulates efficacy of CAR T cells targeting CD19
2022 · Nature Communications · 62 citations
https://doi.org/10.1038/s41467-022-31035-7
J
Jack H. Landmann
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
32
Papers
170
Citations
5
h-index
4
i10-index
Jack H. Landmann is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: CAR-T cell therapy research & CRISPR and Genetic Engineering & vaccines and immunoinformatics approaches. The author has an h-index of 5, co-authored 28 publications.
ORCID: 0000-0002-1128-8914Papers by this author
worksInducing T cell dysfunction by chronic stimulation of CAR-engineered T cells targeting cancer cells in suspension cultures
2023 · STAR Protocols · 14 citations
https://doi.org/10.1016/j.xpro.2022.101954
Supplementary Figure 1 from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024 · 0 citations
https://doi.org/10.1158/2326-6066.26926063.v1
Data from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024 · 0 citations
https://doi.org/10.1158/2326-6066.c.7429375
Supplementary Figure 7 from Rational Protein Engineering to Enhance MHC-Independent T-cell Receptors
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27434308
Supplementary Figure 8 from Rational Protein Engineering to Enhance MHC-Independent T-cell Receptors
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27434305
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat